U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07620535) titled 'Decision Counseling and Follow-up for Shield+ Patients' on May 27.
Brief Summary: Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.
Study Start Date: June, 2026
Study Type: OBSERVATIONAL
Condition:
Colo-rectal Cancer
Intervention:
BEHAVIORAL: Decision Counseling Session
During the decision counseling session, JH research staff will review the Complete Diagnostic Evaluation (CDE) infographic and use an online survey to ...